drugset / Trial / NCT00315432

NATURAL HISTORY-Hepatitis C Virus/ Human Immunodeficiency Virus Coinfection

NCT00315432 ↗

Phase 2 Completed 91 enrolled Ortho Biotech Products, L.P.
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study was to describe the time course and extent of hemoglobin (Hb) changes and the erythropoietic response to PEG-IFN/RBV (Pegylated Interferon and Ribavirin)-induced anemia In HCV(hepatitis C virus)/HIV (human immunodeficiency virus) co-Infected subjects.

Timeline

Start
2000-09
Primary completion
—
Completion
2003-11

Drugs

EvaluationDrugModalityDoseRoute
Background Pegylated Interferon Unknown — —
Background Ribavirin Small molecule — —